Expression of p63, COX-2, EGFR and β-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers

  • Authors:
    • Linda Boldrup
    • Philip J. Coates
    • Ylva Hedberg
    • Björn Sjöström
    • Åke Dahlqvist
    • Karin Nylander
  • View Affiliations

  • Published online on: December 1, 2005     https://doi.org/10.3892/ijo.27.6.1661
  • Pages: 1661-1667
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Squamous cell carcinoma of the head and neck (SCCHN), the 6th most common malignancy in the world, is associated with smoking and has a low 5-year survival rate. Various changes have been described at different stages of SCCHN tumour development, including overexpression of p63, a protein important for development of normal epidermal structures. p63 has been suggested to activate β-catenin, and nuclear accumulation of β-catenin is an important event in many cancers. Elevated COX-2 activity and overexpression of EGFR protein has been shown in a variety of human cancers, including SCCHN. An important question for the pathogenesis of SCCHN is when the genetic changes take place during the natural course of the disease, and whether they appear in clinically normal oral mucosa to predispose tumour development. We mapped the expression of p63, COX-2, EGFR, β-catenin, and PP2A in oral mucosa from smokers/non-smokers and from patients with SCCHN. We also considered if changes occurring in tumours are present in the clinically normal tissue adjacent to the tumour. No direct influence of heavy smoking on the levels of the proteins studied could be seen. Tumours and clinically normal non-neoplastic tissue from SCCHN patients showed increased expression of COX-2 and PP2A. Interestingly, non-neoplastic tissue adjacent to SCCHN also showed increased β-catenin, although this was not seen in tumours. The data support the notion that pre-existing alterations in clinically normal epithelium exist in patients with SCCHN and could be important for the pathogenesis of the disease and for local recurrences.

Related Articles

Journal Cover

December 2005
Volume 27 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Boldrup, L., Coates, P.J., Hedberg, Y., Sjöström, B., Dahlqvist, Å., & Nylander, K. (2005). Expression of p63, COX-2, EGFR and β-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. International Journal of Oncology, 27, 1661-1667. https://doi.org/10.3892/ijo.27.6.1661
MLA
Boldrup, L., Coates, P. J., Hedberg, Y., Sjöström, B., Dahlqvist, Å., Nylander, K."Expression of p63, COX-2, EGFR and β-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers". International Journal of Oncology 27.6 (2005): 1661-1667.
Chicago
Boldrup, L., Coates, P. J., Hedberg, Y., Sjöström, B., Dahlqvist, Å., Nylander, K."Expression of p63, COX-2, EGFR and β-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers". International Journal of Oncology 27, no. 6 (2005): 1661-1667. https://doi.org/10.3892/ijo.27.6.1661